InvestorUnlocking the power of private markets.

Ysios Capital is a Spanish venture capital firm focused on early and mid-stage life science companies, particularly in biotechnology. With a strong emphasis on innovative therapeutic drugs, it manages over €400M across three dedicated funds.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Founded in 2008, Ysios Capital is a leading European venture capital firm based in San Sebastián and Barcelona, Spain. The firm specializes in investing in innovative biotech companies that develop novel therapies for high unmet medical needs. With a focus on both asset-centric companies and product-enabling platform technologies, Ysios Capital aims to support exceptional teams with pioneering science. Over the years, the firm has built a strong portfolio, contributing to the growth of the Spanish biotech ecosystem and achieving significant exits to top-tier pharmaceutical companies.
Ysios Capital invests globally in biotech ventures, concentrating on innovative therapeutic drugs. The firm seeks exceptional teams with pioneering science and the drive to change patients' lives. Their investment strategy includes both asset-centric companies and product-enabling platform technologies, focusing on late preclinical and early clinical projects.
Ysios Capital adds value to its portfolio companies by leveraging its extensive network in the biotech industry, providing strategic guidance, and facilitating partnerships with leading pharmaceutical companies. The firm also supports its companies in navigating the complexities of clinical development and regulatory processes.
Ysios Capital focuses on investing in innovative biotech companies that develop novel therapies for high unmet medical needs. They primarily target late preclinical and early clinical projects, seeking exceptional teams with strong scientific foundations.
Founders can pitch to Ysios Capital through their website at https://ysioscapital.com/contact/ or via email at info@ysioscapital.com. It is recommended to provide a detailed overview of the business, including the team, technology, and market opportunity.
Ysios Capital distinguishes itself through its exclusive focus on biotech and healthcare sectors, leveraging its extensive network in the industry to provide strategic guidance and facilitate partnerships with leading pharmaceutical companies.
Ysios Capital invests globally, with a particular emphasis on Europe and the United States. Their portfolio includes companies from various countries, reflecting their commitment to supporting innovative biotech ventures worldwide.
Ysios Capital invests across various stages, including pre-seed, seed, Series A, Series B, and Series C, with check sizes tailored to the specific needs of each portfolio company.
Ysios Capital actively engages with its portfolio companies, providing strategic guidance, navigating regulatory landscapes, and facilitating access to funding for research and development. They aim to add value beyond capital investment.
Superscout Pro
Is this page right?Reviewed · How the research works